FIELD: medicine. SUBSTANCE: mixed preparation for contraception consists of many stages: the first stage involves 2-4 daily doses being each daily dose has natural estrogens only as an active component; the second stage involves 22-16 daily doses being each daily dose has a combination of at least one natural estrogen and at least one synthetic or natural gestogen as an active component; the third stage involves 2-4 daily doses being each daily dose has natural estrogens only as an active component; the fourth stage involves 2-4 daily doses being each daily dose has pure placebo as pharmaceutical component. Preparation improves the course of cyclic bleeding and decreases or completely eliminates adverse effects. EFFECT: improved quality, enhanced effectiveness of preparation. 4 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED PREPARATION FOR CONTRACEPTION, PHARMACEUTICAL CONTAINER FOR CONTRACEPTION | 1994 |
|
RU2122854C1 |
PHARMACEUTICAL COMBINED PREPARATION FOR HORMONAL CONTRACEPTION | 1995 |
|
RU2165258C2 |
PHARMACEUTICAL COMBINED PREPARATION FOR HORMONAL CONTRACEPTION | 1996 |
|
RU2165259C2 |
DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139885C1 |
CONTRACEPTION METHOD FOR BEING USED BY WOMEN OF REPRODUCTIVE PERIOD NOT ACCESSING PREMENOPAUSAL PERIOD | 1994 |
|
RU2169567C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE | 1995 |
|
RU2179442C2 |
AGENT FOR HORMONAL CONTRACEPTION THAT INHIBITS OVULATION | 1992 |
|
RU2091069C1 |
SCHEME FOR GESTAGEN-ANTIGESTAGEN INTAKE | 1998 |
|
RU2215540C2 |
INTERRUPTED HORMONE-SUBSTITUTION THERAPY WITH LOW ESTROGEN DOSAGES | 2000 |
|
RU2245713C2 |
THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
Authors
Dates
1998-06-27—Published
1996-09-27—Filed